Phycus Biotechnologies provides a bio-conversion platform intended to convert CO2 and diverting GHG emissions from large scale emitters. The company's platform combines microbial technology and metabolic engineering techniques that capture and convert carbon dioxide in to high valued chemical building blocks which are found in a variety ofindustrial products and applications, enabling businesses to find an alternative route for recycling CO2 into fuels and chemicals, economically, while reducing the overall GHG footprint.

Biotechnology

Engineering

Phycus Biotechnologies

Phycus Biotechnologies' headquarters in Toronto, Canada

Description

People (1)

Jobs (0)

Other offices